|
Index of reports
> Cases with Decreased Appetite (15)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydrocortisone (Hydrocortisone Topical) where reactions include decreased appetite. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Hydrocortisone side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Methotrexate Sodium
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin
Possible Hydrocortisone side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin
Possible Hydrocortisone side effects in
Reported by a physician from United States on 2012-08-14
Patient:
Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole
Possible Hydrocortisone side effects in 77 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-20
Patient: 77 year old female
Reactions: Epstein-Barr Virus Infection, Pneumocystis Jiroveci Pneumonia, Lung Disorder, Rheumatoid Lung, Asthenia, Immunosuppression, Epistaxis, Decreased Appetite, Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Enbrel
Dosage: 50 mg, weekly
Indication: Rheumatoid Arthritis
Start date: 2010-11-01
End date: 2012-04-01
Methotrexate Sodium
Dosage: 6 df, weekly
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2010-10-01
End date: 2012-04-01
Hydrocortisone
Dosage: 20 mg, 1x/day
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2010-10-01
Other drugs received by patient: Citalopram Hydrobromide; Levothyroxine Sodium; Leucovorin Calcium; Pravastatin; Omeprazole; Enalapril Maleate; Amlodipine Besylate; Ferrous Sulfate TAB; Aspirin; Duphalac; Acetaminophen
Possible Hydrocortisone side effects in 77 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-09
Patient: 77 year old female
Reactions: Epstein-Barr Virus Infection, Pneumocystis Jiroveci Pneumonia, Lung Disorder, Rheumatoid Lung, Asthenia, Decreased Appetite, Immunosuppression, Epistaxis, Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate Sodium
Dosage: 6 df, weekly
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2010-10-01
End date: 2012-04-01
Hydrocortisone
Dosage: 20 mg, 1x/day
Administration route: Oral
Indication: Rheumatoid Arthritis
Start date: 2010-10-01
Enbrel
Dosage: 50 mg, weekly
Indication: Rheumatoid Arthritis
Start date: 2010-10-01
End date: 2012-04-01
Other drugs received by patient: Omeprazole; Leucovorin Calcium; Duphalac; Levothyroxine Sodium; Pravastatin; Ferrous Sulfate TAB; Enalapril Maleate; Amlodipine Besylate; Citalopram Hydrobromide; Aspirin; Acetaminophen
Possible Hydrocortisone side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-07-05
Patient: 10 year old female
Reactions: Cushingoid, Abdominal Pain, Coagulopathy, Hyponatraemia, Hyperviscosity Syndrome, Headache, Pallor, Somnolence, Hepatic Enzyme Increased, Malaise, Nervous System Disorder, Oedema, Asthenia, Hypertriglyceridaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
Dosage: 8 mg/m2, per day
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: 30 mg, unk
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 10000 iu/m2, per day
Indication: Acute Lymphocytic Leukaemia
Prednisone
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Epirubicin; Methotrexate; Cytarabine; Daunorubicin HCL; Methotrexate W / Cytarabine / Hydrocortisone; Vincristine; Cyclophosphamide; Mercaptopurine
Possible Hydrocortisone side effects in 2 month old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-17
Patient: 2 month old male, weighing 3.0 kg (6.6 pounds)
Reactions: Developmental Delay, Neoplasm Malignant, Growth Retardation, Gynaecomastia, Decreased Appetite
Drug(s) suspected as cause:
Mitotane
Dosage: increased to 2, then 2.5 g/day discontinued at 18 months
Indication: Adrenal Gland Cancer Metastatic
Fludrocortisone Acetate
Hydrocortisone
Possible Hydrocortisone side effects in male
Reported by a physician from United States on 2012-04-30
Patient: male
Reactions: Off Label Use, Decreased Appetite
Drug(s) suspected as cause:
Hydrocortisone
Indication: Prostate Cancer Metastatic
Hydrocortisone
Dosage: tapering dose after 3 weeks
Ketoconazole
Administration route: Oral
Indication: Prostate Cancer Metastatic
Other drugs received by patient: Gonadotropin-Releasing Hormone Agonist
Possible Hydrocortisone side effects in male
Reported by a physician from United States on 2012-04-30
Patient: male
Reactions: Abdominal Pain, Vomiting, Nausea, Flatulence, Rash, Mucosal Inflammation, Dysgeusia, Fatigue, Hepatotoxicity, Diarrhoea, Dizziness, Decreased Appetite
Drug(s) suspected as cause:
Hydrocortisone
Indication: Prostate Cancer Metastatic
Ketoconazole
Administration route: Oral
Indication: Prostate Cancer Metastatic
Other drugs received by patient: Gonadotropin-Releasing Hormone Agonist
Possible Hydrocortisone side effects in 20 year old female
Reported by a consumer/non-health professional from United States on 2012-03-27
Patient: 20 year old female, weighing 74.8 kg (164.6 pounds)
Reactions: Oropharyngeal Pain, Arthralgia, Arthritis Infective, Oesophagitis, Blood Culture Positive, Hypoxia, Colitis, Joint Effusion, Sinusitis, Decreased Appetite, Pharyngitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 30 mg, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-27
Methotrexate
Dosage: 500 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-24
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-01-17
Cyclophosphamide
Dosage: 440 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Hydrocortisone
Dosage: 15 mg, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-27
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-03-02
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-01-17
Pegaspargase
Dosage: 2500 unk, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-07
Prednisone TAB
Dosage: 20 mg/m2, cyclic
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-14
Methotrexate
Dosage: 4500 mg/m2, unk
Possible Hydrocortisone side effects in 20 year old female
Reported by a consumer/non-health professional from United States on 2012-03-16
Patient: 20 year old female, weighing 74.8 kg (164.6 pounds)
Reactions: Oropharyngeal Pain, Culture Stool Positive, Oesophagitis, Chest Pain, Blood Culture Positive, Hypoxia, Joint Effusion, Cholecystitis, Sinusitis, Pharyngitis, Decreased Appetite, Helicobacter Infection, Arthralgia, Arthritis Infective, Colitis, Sleep Apnoea Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 30 mg, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-27
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-01-17
Methotrexate
Dosage: 4500 mg/m2, unk
Prednisone TAB
Dosage: 20 mg/m2, cyclic
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-14
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Hydrocortisone
Dosage: 15 mg, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-27
Methotrexate
Dosage: 500 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-24
Pegaspargase
Dosage: 2500 unk, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-07
Cyclophosphamide
Dosage: 440 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-02-28
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-03-02
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-01-17
Possible Hydrocortisone side effects in male
Reported by a physician from United States on 2012-03-07
Patient: male
Reactions: Abdominal Pain, Vomiting, Nausea, Flatulence, Rash, Dysgeusia, Mucosal Inflammation, Fatigue, Hepatotoxicity, Diarrhoea, Dizziness, Decreased Appetite
Drug(s) suspected as cause:
Hydrocortisone
Indication: Prostate Cancer Metastatic
Ketoconazole
Administration route: Oral
Indication: Prostate Cancer Metastatic
Other drugs received by patient: Gonadotropin-Releasing Hormone Agonist
Possible Hydrocortisone side effects in 20 year old female
Reported by a physician from United States on 2012-03-01
Patient: 20 year old female, weighing 86.6 kg (190.5 pounds)
Reactions: Oropharyngeal Pain, Arthralgia, Oesophagitis, Arthritis Infective, Blood Culture Positive, Colitis, Joint Effusion, Decreased Appetite, Pharyngitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-01-17
Hydrocortisone
Dosage: unk mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-07
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-01-27
Cytarabine
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-07
Pegaspargase
Dosage: 2500 unk, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-07
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-07
Prednisone
Dosage: 20 mg/m2, cyclic
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-04
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-07
Possible Hydrocortisone side effects in 20 year old female
Reported by a consumer/non-health professional from United States on 2012-02-20
Patient: 20 year old female, weighing 86.6 kg (190.5 pounds)
Reactions: Oesophagitis, Blood Culture Positive, Colitis, Oropharyngeal Pain, Pharyngitis, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-07
Prednisone
Dosage: 20 mg/m2, cyclic
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-04
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-07
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-01-27
Cytarabine
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-07
Hydrocortisone
Dosage: unk mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-07
Pegaspargase
Dosage: 2500 unk, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-02-07
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-01-16
End date: 2012-01-17
Possible Hydrocortisone side effects in male
Reported by a physician from United States on 2012-01-31
Patient: male
Reactions: Off Label Use, Decreased Appetite
Drug(s) suspected as cause:
Hydrocortisone
Dosage: tapering dose after 3 weeks
Ketoconazole
Administration route: Oral
Indication: Prostate Cancer Metastatic
Hydrocortisone
Indication: Prostate Cancer Metastatic
Other drugs received by patient: Gonadotropin-Releasing Hormone Agonist
|
